BACKGROUND: The mannose receptor (MR) is involved in the initiation of the immune response and regulation of homeostasis during inflammation and tissue remodeling. METHODS: Distribution, endocytosis and possible natural ligand tumor associated glycoprotein-72 (TAG-72) for the MR have been examined by immunohistology, immunocytochemistry and flow cytometry at the maternal-fetal interface, characterized by extensive tissue remodeling. RESULTS: Contrary to disseminated distribution of the MR positive (MR1 ) cells in term placenta, the MR1 cells of early pregnancy decidua intimately surrounded glands and followed tissue distribution of CD14 positive cells. The mannose receptor was present on freshly isolated first trimester decidual mononuclear cells and distributed mostly on macrophages (77.08 6 10.55%, mean 6 SD). The expression of the MR on CD14 positive cells decreased following 18 h culture (P < 0.01) and was accompanied by the reduction of fluorescein isothiocyanate (FITC)-dextran uptake. PAM-1 anti-MR antibody, mannan and TAG-72 reduced FITC-dextran uptake by decidual macrophages. CONCLUSIONS: These data indicate that the MR1 macrophages, surrounding early decidual glands, are able to internalize ligands for carbohydrate recognition domain of the receptor, including decidual secretory phase mucin TAG-72.
Introduction
The mannose receptor (MR) or CD206 was recognized as endocytic receptor on the surface of alveolar macrophages (Wileman et al., 1986) and soon after that on dendritic cells (Engering et al., 1997) , Kaposi sarcoma cells (Uccini et al., 1997) , lymphatic and hepatic endothelium, kidney mesangial cells, perivascular microglia (Linehan et al., 1999) and retinal pigment epithelium (Shepherd et al., 1991) . Sequence analyses of placental MR cDNA predicted that MR belongs to type I membrane protein of C type lectin super family (Taylor et al., 1990) . It has a potential role in antigen capture and transport . Three different extracellular domains of the MR: cystein rich domain, fibronectin type II repeat and carbohydrate recognition domain (CRD) are able to bind foreign and self molecules (sulfated glycoproteins or glycoproteins containing mannose, fucose and N glucosamine residues) in a Ca 2þ dependent manner and endocytose them by clathrin mediated endocytosis (East and Isacke, 2002) . Beside endocytosis, cytoplasmic domain can also mediate phagocytosis of larger particles (Kang and Schlesinger, 1998; Rivera-Marrero et al., 2002) . It is possible that MR itself is not responsible for phagocytosis, but rather for binding particles with terminal mannose residues and engaging a classical phagocytic receptor to drive phagocytic machinery (Kawabata, 2002) . This process is primarily used to eliminate microorganisms, apoptotic or unwanted cells and plays a critical role in innate and adaptive immunity and tissue remodeling (Aderem and Underhill, 1999) .
Extensive remodeling events occur during embryo implantation and early pregnancy, comprising trophoblast invasion, infiltration of decidua by maternal immunocompetent NK cells, T lymphocytes and antigen presenting cells (macrophages and dendritic cells), differentiation of glandular epithelium and transformation of spiral arteries into uteroplacental vessels (Fazleabas and Strakova, 2002; Trundley and Moffett, 2004) . Antigens of paternal origin expressed on trophoblast cells come into close contact with maternal leukocytes present in the decidua. These interactions, instead of bringing about a detrimental immune response, cause tolerance supported by progesterone (Szekeres-Bartho and Wegmann, 1996; Szekeres-Bartho et al., 2001 ) and set of complex cytokine and chemokine production (Jerzak and Bischof, 2002; Piccinni, 2002; Miyazaki et al., 2003) . Recent data show that engaging of the CRD of the MR by specific antibody, as well as glycoproteins, could lead to triggering of an anti-inflammatory and tolerogenic program in dendritic cells (Chieppa et al., 2003) . The interaction of MR with glycoproteins at the maternal-fetal interface could promote Th2 cytokine production, indispensable for maintaining pregnancy, following the narrow peri-implantation period (Chaouat et al., 1999; Chaouat et al., 2003) . Although tumor associated glycoprotein-72 (TAG-72) is the marker of various human malignancies (Katari et al., 1990) , it is produced throughout normal human female genital tract (Osteen et al., 1992) in a progesterone dependent manner (Osteen et al., 1990 ). With its high glycosylation level, TAG-72 could be possible natural ligand for the MR. Although the MR protein was originally isolated from human placenta (Lennartz et al. 1987) , little is known about the distribution and function of this receptor at the maternal -fetal interface, which is rich in progesterone (3 mg/g of decidual tissue) (Szekeres-Bartho, 1992) . The aim of our study was to analyze expression and distribution of the MR in the first trimester pregnancy decidua and term placenta, MR endocytic activity and possible binding properties of progesterone dependent TAG-72 to the CRD of the MR.
Materials and methods

Tissues
The Ethics Committee of the Medical Faculty, University of Rijeka, approved the study. Samples of decidual tissues were obtained from healthy pregnant women who were undergoing elective termination of a 6 -10 week pregnancy and had at least one live born child. Term placentas were obtained following normal vaginal delivery.
Immunohistology
Samples of the first trimester decidua and term placenta were snap frozen, cut into tissue sections and fixed in cold acetone (Kemika, Zagreb, Croatia). Sections of both tissues were stained by primary mouse immunoglobulin G (IgG) 2a anti-CD14 monoclonal antibody (anti-CD14 mAb) (School of Medicine, Rijeka, Croatia) and/or mouse anti-human anti-MR monoclonal antibody of PAM-1 clone (PAM-1 anti-MR mAb) (Mario Negri Institute for Farmacological Research, Milan, Italy, Chieppa-Wechii) using DAKO Envision Doublestain System (DAKO, Glostrup, Denmark). The manufacturer's instructions were followed for performing an indirect immunoperoxidase and alkaline phosphatase (AP)-staining methods. Briefly, sections pretreated with kit blocking solution were incubated (30 min) with anti-CD14 mAb (undiluted supernatant) or mouse IgG2a (School of Medicine, Rijeka, Croatia) diluted 1:4 in Tris-buffered saline (TBS, 0.05 M Tris containing 0.3 M NaCl; both from Kemika) and 0.1% Tween 20 (Sigma, München, Germany), pH 7.2-7.6, and followed by incubation (30 min) with the labelled polymer, horseradish peroxidase (HRP) (included in the kit). The initial reaction was completed with 5 min incubation of the liquid 3,3-diaminobenzidine þ substrate-chromogen which resulted in a brown-colored precipitate at the antigen site. Incubation with Doublestain block (3 min) removed any cross-reactivity that might be present. The specimens were then incubated (30 min) with the second primary PAM-1 anti-MR mAb at a concentration of 1 mg/100 ml of TBS or mouse IgG1 (Medical School, Rijeka, Croatia) diluted 1:4 in TBS, followed by the incubation of the labelled polymer, AP (included in the kit). The second antigen stain was completed with 5 min incubation with the Fast Red substratechromogen which resulted in a red-colored precipitate at the antigen site. Nuclei were counterstained with haematoxylin (Kemika) and specimens were mounted using Liquefy Dako Glycergel (Dako).
Isolation of decidual cells
Decidual tissue was cut into pieces, exposed to collagenase digestion (equal volume of tissue and 0.5% collagenase type IV, Sigma) at 37 8C for 60 min with gentle mixing on the magnetic stirrer. The obtained cell suspension was passed twice through 100 mm nylon mesh (Becton Dickinson, Franklin Lakes, NJ) for tissue debris elimination and centrifuged at 600 g for 10 min. The pellet was resuspended in RPMI 1640 (Institute of Immunology, Zagreb, Croatia), overlaid on Lymphoprep (Nycomed Pharma AS, Oslo, Norway) and centrifuged at 800 g for 20 min. Decidual mononuclear cells (DMC) were collected from the interface, washed twice in RPMI 1640, resuspended in cell culture medium RPMI 1640 supplemented with L-glutamate (2 mM), penicillin (1 £ 10 25 U/l), streptomycin sulphate (0.05 g/l), 10% fetal calf serum (FCS) (all from Gibco, Gaithersburg, MD) and used immediately or cultured overnight (18 h) in 100 £ 20 mm tissue culture Petri dishes (TPP, Switzerland) at 37 8C in a humidified atmosphere with 5% CO 2 .
Immunocytochemistry
Freshly isolated DMC were adjusted to 8 £ 10 5 /ml of phosphatebuffered saline (PBS) and 100 ml of the suspension was centrifuged onto a glass microscope slide (500 r.p.m. for 5 min). The cells on the slides were dried at room temperature and fixed in cold acetone. Labeling of the MR was carried out by immunoperoxidase-staining method using a LSAB-HRP kit (DAKO). Briefly, sections preincubated with LSAB-HRP kit blocking solution were labeled (30 min) with PAM-1 anti-MR mAb at 1 mg/100 ml in PBS (Na 2 HPO 4 .12H 2 O 33.9 mM, NaCl 136.8 mM, KH 2 PO 4 3 mM of distilled water, all from Kemika)/0.05% bovine serum albumin (BSA, Sigma). Mouse IgG1 supernatant diluted 1:4 in PBS/0.05% BSA was used as isotype matched control. Incubation (10 min) with secondary antimouse biotinylated antibodies, was followed by incubation with streptavidin for 10 min (both included in the LSAB-HRP kit). Reaction was developed using aminoethyl-carbasol (Sigma) and nuclei were counterstained with haematoxylin.
Direct and indirect immunofluorescence DMC were investigated immediately after isolation or following 18 h culture in the medium only. Some freshly isolated DMC were pretreated with TAG-72 (Sigma) for 30 min on ice (50, 100, 200 or 400 U/ml). One unit (U) is an arbitrary unit related to a reference antigen preparation using the CIS-RIA method. Unconjugated primary PAM-1 anti-MR mAb 1 mg/10 5 cells/100 ml of fluorescenceactivated cell sorter (FACS) buffer NaCl (140 mM), KH 2 PO 4 (1.9 mM), Na 2 HPO 4 (16.5 mM), KCl (3.75 mM) (all from Kemika), Na 2 EDTA (0.96 mM, Fluka, Buchs, Switzerland), NaN 3 (1.5 mM, Difco, Detroit, Michigan, USA), 2% FCS or mouse fluorescein isothiocyanate (FITC)-conjugated IgG1/PE-conjugated IgG2a (Becton-Dickinson, Erembodegen, Belgium) was added to the cells which receptors for Fc fragment of antibodies were blocked. Cells were incubated for 30 min on ice, washed twice in FACS buffer and incubated with FITC-conjugated goat anti-mouse immunoglobulins (Becton-Dickinson) for 30 min on ice. After two washes, PE-conjugated anti-CD14 or PE-conjugated anti-CD83 monoclonal antibody (Becton-Dickinson) was added for 30 min on ice. Following two washes, the pellet was resuspended in 400 ml of 2% paraformaldehyde. Cells were acquired and analyzed in a flow cytometer (Becton Dickinson FACSCalibur) using CellQuestPro software (BD Biosciences, San Jose, California, CA). We acquired 10 4 DMC in a gate that comprises MR positive events (back gating). The results were expressed as the percentage of MR or mean fluorescence intensity (MFI) for the MR.
Endocytosis
Freshly isolated or 18 h cultured DMC (2 £ 10 5 per sample) were initially incubated 20 min with 10% heat inactivated FCS. The cells were then washed and resuspended in ice-cold medium for endocytosis [Solution A: MgCl 2 .6H 2 O 0.5 mM, CaCl 2 1.17 mM and Solution B: NaCl 136.8 mM, KCl 2.68 mM, Na 2 HPO 4 7.95 mM, KH 2 PO 4 1.46 mM (all from Kemika) in ratio 1:1, pH 7.4]. Following 10 min incubation on ice the cells were pelleted and treated with TAG-72 (50, 100, 200 or 400 U/ml), PAM-1 anti-MR mAb (10 or 20 mg/ml), mannan (50, 100, 200 or 400 mg/ml, Sigma) or medium in total volume of 100 ml for 30 min on ice. Then ice-cold or warm (37 8C) FITC-dextran (Sigma-Aldrich Chemie, Steinheim, Germany) was added to the cells at the final concentration 0.5 mg/ml and the cells were kept on ice or 37 8C for 30 min. Endocytosis was stopped by washing the cells with ice-cold FACS buffer and fixing with 4% paraformaldehyde (10 min at room temperature). After washes, the cells were incubated for 30 min with PE-conjugated anti-CD14 mAb or FITC-conjugated IgG1/PE-conjugated IgG2a, washed twice and resuspend in 2% paraformaldehyde. The cells of CD14 positive phenotype were analyzed in a flow cytometer and data was expressed as MFI for FITC-dextran.
Statistical analysis
Non-parametric Mann -Whitney U test was used to evaluate differences between groups. Differences were considered significant when P , 0.05. Data are expressed as mean^SD. Statistical analysis was carried out with Statistics for Windows, Kernel release 5.5 (StatSoft, Inc., Tulsa, OK).
Results
Assessment and tissue distribution of the MR in first trimester decidua and term placenta
The MR positive cells found in frozen tissue sections of the first trimester normal human pregnancy decidua were compared with the isotype control ( Figure 1A ). They were distributed much more around the glands and significantly less in the stroma, resembling the distribution of decidual CD14 positive cells, as shown by double labeling of the MR and CD14 molecule (indicated by the short arrows, Figure 1A ). Approximately half of the CD14 positive cells were also MR positive ( Figure 1A) . In both parts of the frozen sections of term placenta (maternal decidua and fetal villa), CD14 positive cells were found randomly distributed ( Figure 1B and C). They overlapped with the distribution of MR positive cells and although CD14 positive/MR positive cells were found (indicated by the short arrows), there were significantly fewer double labeled than single labeled CD14 positive cells ( Figure 1B and C) . There were more MR positive cells than CD14 positive Hofbauer cells in the villi, according to the MR expression on endothelial cells inside the vessels (indicating by the long arrows, Figure 1C ).
Assessment and phenotype of MR positive cells in the suspension of first trimester DMC Visualization of the MR positive cells within first trimester DMC ( Figure 1D ) allows further in vitro investigation of these cells. The expression and distribution of the MR on freshly isolated DMC was analyzed by flow cytometry within R1 gate set for the MR positive events (back gating using Cell Quest Pro Software, Becton-Dickinson) (Figure 2A ). This gate comprises larger cells, of more complex granularity, than the characteristic lymphocyte gate and represents decidual adherent cells. Our previous study showed that the decidual adherent cell population comprises mostly stromal cells and macrophages, but also less frequent glandular, endothelial and extravillous trophoblast cells (Sotosek et al., 1999) , as well as some dendritic cells (manuscript in preparation). Therefore, all of these cell types were included in the analysis of MR expression within R1 gate. In the representative sample , 9% of MR positive cells were found ( Figure 2C and D) compared to the isotype control ( Figure 2B ), which corresponds to 14.51^6.44% of MR positive cells in 10 experiments. In the sample shown, 82.26% of the cells within R2 gate, representing the MR positive population, were CD14 positive ( Figure  2E ), while 7.84% were CD83 positive ( Figure 2F ). These data also correspond to 77.08^10.55% for the distribution of the MR on CD14 positive cells or 12.48^5.46% on CD83 þ -cells, observed in 7 -10 experiments. 
Mannose receptor mediated endocytosis in human decidua
Regulation of MR expression on the first trimester decidual CD14 positive cells Since decidual macrophages are the most frequent MR expressing cells, in our further investigations we followed the expression and function of the MR exclusively on CD14 positive cells. In R1 gate (back gating for the MR positive events) that comprises decidual adherent cells, 14.8% CD14 positive cells were found compared to the isotype control (0.95%) (Figure 3A) , which corresponds to 15.68^7.187% of CD14 positive cells in seven experiments. Further, CD14 positive events were gated (R2 gate) and the expression of the MR was analyzed on the cells belonging to R1 and R2 gates ( Figure 3A) . In the shown sample of freshly isolated decidual cells, 46.7% of CD14 macrophages expressed MR compared to the isotype control ( Figure 3A) . These data correspond to the mean values of the MR expression on CD14 positive cells (49.38^22.45%) and only slightly decreased following 18 h culture to 36.6^19.99% ( Figure 3B ). Contrary to the percentage of the MR positive macrophages, a statistically significant decrease of the MFI for the MR on CD14 positive cells following 18 h culture in vitro was observed (P , 0.01, Figure 3C ). The average number of the MR per cultured CD14 positive cell (97.71^60.8) is about three times lower than the MR on CD14 positive cells from freshly isolated suspensions (270^122.34).
Endocytosis of the first trimester decidual CD14 positive cells Figure 4 shows the sample of flow cytometer analysis of cellular uptake of FITC -dextran. Gate R1 comprises MR positive events and gate R2 CD14 positive events. As the internalization of the MR and endocytosis is maximally reduced in cold, FITC -dextran uptake on ice was used as the control (open charts). Macrophages from freshly isolated cells (Column A) belonging to R1 and R2 gates internalized FITC -dextran at 37 8C more efficiently (MFI 205.55 ) than 18 h cultured cells (Column B) belonging to the same gates (MFI 128.05) (solid charts). Eight experiments were performed and a significant difference in the MFI for FITCdextran was found when comparing CD14 positive cells from freshly isolated suspensions (194.68^140.53) to 18 h cultured cells (95.68^60.6) (P ¼ 0.046, Figure 4C ). Macrophages from freshly isolated DMC pretreated for 30 min with increasing concentrations of mannan internalized FITC -dextran less efficiently ( Figure 5A ). The effect was dose dependent and a statistically significant decrease at the levels P ¼ 0.01, P ¼ 0.002, P ¼ 0.006 and P ¼ 0.001 was observed when MFI for FITC -dextran of untreated cells (175.5^99.81) was compared to the cells pretreated with 50 mg/ml (90.57^38.41), 100 mg/ml (66.81^39.96), 200 mg/ml (71.45^48.86) or 400 mg/ml (57.06^34.89) mannan, respectively. Macrophages pretreated with PAM-1 anti-MR mAb showed less efficient endocytosis of FITCdextran compared to untreated cells ( Figure 5B ). Statistical significance (P ¼ 0.03) was found when CD14 positive cells treated with 20 mg/ml of PAM-1 anti-MR mAb (97.82^28.23) were compared with untreated cells (175.5^99.81). FITC -dextran uptake of IgG1 treated cells (148.43^24.02) did not differ significantly from the FITCdextran uptake by untreated cells ( Figure 5B ).
Differential binding of TAG-72 to the first trimester CD14 positive cells
Macrophages from DMC pretreated with TAG-72 showed a dose dependent reduction of PAM-1 anti-MR mAb binding ( Figure 6A ). TAG-72 at a concentration of 200 and 400 U/ml decreased MFI for the MR on decidual CD14 positive cells to 161.8^41.38 or 67.66^27.8, respectively, compared to the untreated cells (318.2^120.9, P ¼ 0.001). Figure 6B shows FITC -dextran uptake in three different samples (shown in the columns) of untreated cells or cells treated with 50, 100, 200 or 400 U/ml of TAG-72. Solid lines of the charts represent endocytosis at 37 8C, while dashed lines represent control endocytosis on ice. MFI for FITC -dextran on CD14 positive cells at 37 8C decreased on a dose dependent manner approaching the controls. Statistical significance was observed at the level P ¼ 0.049 when untreated cells (301.72^109.06) were compared to the cells treated with 400 U/ml of TAG-72 (75.37^51.05).
Discussion
We have demonstrated MR protein expression on isolated early decidual macrophages and CD83 positive dendritic cells, although this molecule is highly recycling (Leteux et al., 2000) . The decrease in MFI for the MR may well reflect the differences in the differential adhesion properties of macrophages in vitro with macrophage detaching after short term culture, than in vitro activation of these cells.
The changes in MR expression on decidual macrophages reflected their endocytic activity measured by FITC -dextran uptake. FITC-dextran is the ligand for the CRD of the MR and is internalized by a receptor-mediated pathway (Kato et al., 2000; East and Isacke, 2002) . It is interesting that neither monoclonal PAM-1 anti-MR antibody nor mannan, as the specific ligands for CRD (Chieppa et al., 2003) even at the highest concentrations used, could completely block FITC -dextran uptake by freshly isolated decidual CD14 positive cells, although a statisticaly significant decrease was observed. This is possibly due to the fact that FITC -dextran, at a concentration of 0.5 mg/ml enters the cell by an alternative pathway-fluid phase endocytosis-that can not be influenced by binding of the MR (Shurety et al., 1998) . It is also proposed that the alternative pathway of endocytosis increases when the classical receptor mediated endocytosis pathway is somehow disabled (Lamaze and Schmid, 1995) . It is possible that glycoproteins produced within decidual tissue bind to the MR expressing cells, as their natural ligands. Crosslinking of the MR with secretory phase glycoproteins and segregation on the cell membrane may interfere with the internalization routing of a foreign antigen expressed on trophoblast cells, resulting in decreased endocytosis, processing and presentation of trophoblast antigens during (Katari et al., 1990) , as well as endometrium of normal female reproductive tract (Osteen et al., 1990 (Osteen et al., , 1992 . Intense immunostaining in endometrial epithelial cells was limited to the secretory menstrual interval, while TAG-72 was not found in proliferative endometrium (Lessey and Pindzola, 1993) . As TAG-72 appearance correlated with progesterone secretion and accumulation of maternal leukocytes in endometrium (Brackin et al., 2002) , we hypothesized the presence of TAG-72 in the first trimester pregnancy decidua and analyzed its possible binding properties to decidual macrophages. Indeed, TAG-72 significantly diminished PAM-1 anti-MR mAb binding on early decidual CD14 positive cells in a dose dependent manner and reduced FITC -dextran uptake by the same cells. It implies that TAG-72 could be the natural ligand for the CRD of the MR in early pregnancy decidua and might be involved in induction of a distinct profile of cytokines and chemokines inefficient in supporting Th1 mediated response, leading to T cell anergy (Chieppa et al., 2003) specific for the mucosal surfaces, rich in glycoproteins (Akbari et al., 2001; Weiner, 2001) . Indeed, early decidual macrophages are able to produce various type of cytokines (Kanzaki et al., 1992; Chaouat et al., 1999; Kitaya et al., 2000) and to regulate the cytolytic potential of decidual cytolytic T and NK cells (Sotosek et al., 1999; Laskarin et al., 2002) . However, these cells are hyporeactive to trophoblast alloantigens (Perhar et al., 1989; Verma et al., 2000) . On the other hand, a few studies indicated that MR participates in cell activation and increasing cytolytic functions (Oshumi and Lee, 1987; Shibata et al., 1997) . It could be due to activation of the MR with the ligands bound to the epitopes outside CRD, which may be unable to induce anti-inflammatory program, like anti-MR mAb of 19.2 clone in dendritic cells (Chieppa et al., 2003) . A sudden drop in progesterone and diminished glycoprotein production at the end of pregnancy, might enable third trimester decidual macrophages to enhance endocytosis, processing and presentation of the trophoblast antigens by the MR. It might induce Th1 cytokine production and cytotoxic functions of decidual lymphocytes and might promote labour.
